BayMedica

At the last Benzinga Cannabis Capital Conference, industry experts discussed the rising demand for rare cannabinoids, which are lesser-known compounds found in the cannabis plant known for their unique therapeutic properties. Panelists Jerry Griffin VP of Sales & Marketing from BayMedica...

InMed Pharmaceuticals (NASDAQ: INM) announced on Monday that it has entered into a definitive agreement to acquire BayMedica Inc., a private company that manufactures rare cannabinoids. Once the agreement is completed, InMed could become a global leader in the manufacturing...